Share on LinkedInShare on LinkedIn

ARTICLE · 18 AUGUST 2020

Indefiniteness: Bad Translation, Lack Of Definition Or Both?

The Federal Circuit affirms the lower court ruling that "half-liquid" translated from the original Italian "semiliquido" is indefinite in IBSA Institut Biochimique, S.A., Altergon, S.A., ...

United StatesIntellectual Property

The Federal Circuit affirms the lower court ruling that "half-liquid" translated from the original Italian "semiliquido" is indefinite in IBSA Institut Biochimique, S.A., Altergon, S.A., IBSA Pharma Inc. v. Teva Pharmaceuticals USA, Inc. (Fed. Cir. July 31, 2020). http://www.cafc.uscourts.gov/sites/default/files/opinions-orders/19-2400.OPINION.7-31-2020_1628842.pdf

IBSA is the owner of U.S. patent no. 7,723,390 and Teva filed an Abbreviated New Drug Application that included a certification of invalidity of that patent. Claim 1 of that patent is

1. A pharmaceutical composition comprising thyroid hormones or their sodium salts in the form of either:

a) a soft elastic capsule consisting of a shell of gelatin material containing a liquid or half-liquid inner phase comprising said thyroid hormones or their salts in a range between 0.001 and 1% by weight of said inner phase, dissolved in gelatin and/or glycerol, and optionally ethanol, said liquid or half-liquid

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from